We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+11.1%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$292M
AUM Growth
+$16.8M
Cap. Flow
-$7.89M
Cap. Flow %
-2.7%
Top 10 Hldgs %
29.91%
Holding
120
New
8
Increased
27
Reduced
29
Closed
13

Top Buys

Rank Stock Value
1
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$12.2M
2
ARWR icon
Arrowhead Research
ARWR
+$3.01M
3
BIIB icon
Biogen
BIIB
+$2.76M
4
GILD icon
Gilead Sciences
GILD
+$1.62M
5
BIDU icon
Baidu
BIDU
+$1.52M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.53M
2
CLDX icon
Celldex Therapeutics
CLDX
+$6.14M
3
YHOO
Yahoo Inc
YHOO
+$5.12M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.85M
5
NDLS icon
Noodles & Co
NDLS
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 22.95%
2 Energy 16.91%
3 Communication Services 13.82%
4 Industrials 9.86%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWSA icon
76
News Corp Class A
NWSA
$16.6B
$510K 0.17%
28,276
-249
-0.9% -$4.3K
AEP icon
77
American Electric Power
AEP
$66.6B
$504K 0.17%
10,790
– –
TROW icon
78
T. Rowe Price
TROW
$23.7B
$497K 0.17%
5,930
– –
VIAB
79
DELISTED
Viacom Inc. Class B
VIAB
$480K 0.16%
5,500
– –
PH icon
80
Parker-Hannifin
PH
$125B
$479K 0.16%
3,727
– –
INTU icon
81
Intuit
INTU
$97.9B
$469K 0.16%
6,150
– –
MRK icon
82
Merck
MRK
$366B
$425K 0.15%
8,908
– –
BMY icon
83
Bristol-Myers Squibb
BMY
$136B
$377K 0.13%
7,097
– –
FISV
84
Fiserv Inc
FISV
$28.3B
$360K 0.12%
12,200
– –
LAMR icon
85
Lamar Advertising Co
LAMR
$15.3B
$347K 0.12%
6,650
– –
WMT icon
86
Walmart Inc
WMT
$820B
$343K 0.12%
13,065
– –
PG icon
87
Procter & Gamble
PG
$334B
$326K 0.11%
4,000
– –
LLL
88
DELISTED
L3 Technologies, Inc.
LLL
$321K 0.11%
3,000
– –
COR icon
89
Cencora
COR
$61.5B
$312K 0.11%
4,436
– –
HES
90
DELISTED
Hess
HES
$299K 0.1%
3,600
– –
FCX icon
91
Freeport-McMoran
FCX
$110B
$287K 0.1%
7,600
– –
MDSO
92
DELISTED
Medidata Solutions, Inc.
MDSO
$254K 0.09%
4,200
– –
GS icon
93
Goldman Sachs
GS
$301B
$253K 0.09%
1,425
– –
QCOM icon
94
Qualcomm
QCOM
$175B
$241K 0.08%
3,242
– –
ED icon
95
Consolidated Edison
ED
$39.8B
$240K 0.08%
4,350
– –
XLV icon
96
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$222K 0.08%
4,000
– –
JPM icon
97
JPMorgan Chase
JPM
$951B
$208K 0.07%
+3,558
New +$195K
TI
98
DELISTED
Telecom Italia
TI
$115K 0.04%
11,500
– –
ACCO icon
99
Acco Brands
ACCO
$396M
$73K 0.03%
10,853
– –
BMRN icon
100
BioMarin Pharmaceuticals
BMRN
$12.5B
– –
-90,514
Closed -$6.53M
1 2 3
4
5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Private Capital Advisors held 120 positions worth $292M, up 6.1% from $275M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Private Capital Advisors's Q4 2013 filing shows 8 new, 27 increased, 29 reduced and 13 closed positions. Its largest new stake was SANGAMO THERAPEUTICS INC: 1,059,000 shares worth $14.7M. The largest sale was BioMarin Pharmaceuticals, an estimated $6.53M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • Private Capital Advisors's largest Q4 2013 buy was SANGAMO THERAPEUTICS INC: 1,059,000 shares worth $14.7M.
  • Private Capital Advisors added most to Biogen in Q4 2013, an estimated $2.76M increase.
  • Private Capital Advisors's biggest Q4 2013 reduction was Alphabet (Google) Class C, cutting an estimated $4.85M.
  • Private Capital Advisors fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $6.53M.
  • Private Capital Advisors's ten largest holdings make up 30% of its $292M portfolio in Q4 2013.
  • Private Capital Advisors opened 8 new positions and closed 13 in Q4 2013.
  • Private Capital Advisors's portfolio value rose 6.1% quarter-over-quarter to $292M.

Based on Private Capital Advisors's 13F filing for Q4 2013, filed 31 Jan 2014.